BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, December 2, 2024
Breaking News: Healing a health divide (that’s long overdue)
See today's BioWorld Science
Home
» Shanghai Qilu Pharmaceutical Research and Development Centre identifies new PRT5 inhibitors
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Cancer
Shanghai Qilu Pharmaceutical Research and Development Centre identifies new PRT5 inhibitors
Feb. 15, 2023
No Comments
Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. has presented protein arginine
N
-methyltransferase 5 (PRMT5) inhibitors reported to be useful for the treatment of cancer.
BioWorld Science
Cancer
Patents
